Rolf Marschalek

10.8k total citations · 1 hit paper
225 papers, 5.4k citations indexed

About

Rolf Marschalek is a scholar working on Molecular Biology, Hematology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Rolf Marschalek has authored 225 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 145 papers in Molecular Biology, 120 papers in Hematology and 70 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Rolf Marschalek's work include Acute Myeloid Leukemia Research (107 papers), Acute Lymphoblastic Leukemia research (69 papers) and Protein Degradation and Inhibitors (33 papers). Rolf Marschalek is often cited by papers focused on Acute Myeloid Leukemia Research (107 papers), Acute Lymphoblastic Leukemia research (69 papers) and Protein Degradation and Inhibitors (33 papers). Rolf Marschalek collaborates with scholars based in Germany, United States and France. Rolf Marschalek's co-authors include Theo Dingermann, Eric Kowarz, Claus Meyer, Johann Greil, Martin Reichel, Marc Anders, Rudolf Fahlbusch, U. Schrell, Gabriele Margareta Siegler and Oskar A. Haas and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Rolf Marschalek

216 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies

2022 109 citations Rolf Marschalek et al. profile →

Peers

Countries citing papers authored by Rolf Marschalek

Since Specialization

Citations

This map shows the geographic impact of Rolf Marschalek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Marschalek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Marschalek more than expected).

Fields of papers citing papers by Rolf Marschalek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rolf Marschalek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Marschalek. The network helps show where Rolf Marschalek may publish in the future.

Co-authorship network of co-authors of Rolf Marschalek

This figure shows the co-authorship network connecting the top 25 collaborators of Rolf Marschalek. A scholar is included among the top collaborators of Rolf Marschalek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rolf Marschalek. Rolf Marschalek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CRISPR/Cas9-mediated t(4;11) translocation in human hematopoietic stem/precursor cells demonstrates plasticity to differentiate into either the myeloid or lymphoid lineage 2025 ·Leukemia ·(unknown), Patrizia Larghero, (unknown), (unknown), Dörthe Brüggmann, (unknown), Frank Louwen, Rolf Marschalek	0
2	Quantification of objective concentrations of DNA impurities in mRNA vaccines 2025 ·Vaccine ·Stefanie Kaiser, (unknown), (unknown), (unknown), Rolf Marschalek	8
3	Inhibition of DYRK1B BY C81 impedes inflammatory processes in leukocytes by reducing STAT3 activity 2025 ·Cellular and Molecular Life Sciences ·(unknown), (unknown), (unknown), Anne Wolf, (unknown), Dominik C. Fuhrmann, Dominique Thomas, Robert Gurke, Martin P. Schwalm, Lena M. Berger, (unknown), (unknown), Rolf Marschalek, Gerd Geißlinger, Stefan Knapp, Thomas Langmann, Franz Bracher, Andreas Weigert, Robert Fürst	1
4	Prenatal origin of NUTM1 gene rearrangement in infant B‐cell precursor acute lymphoblastic leukaemia 2024 ·British Journal of Haematology ·Michela Bardini, Grazia Fazio, L Corral Abascal, Claus Meyer, Oscar Maglia, (unknown), (unknown), (unknown), Rolf Marschalek, Carmelo Rizzari, Andrea Biondi, Giovanni Cazzaniga	3
5	SARS-CoV-2: The Virus, Its Biology and COVID-19 Disease-Counteracting Possibilities 2023 ·Frontiers in Bioscience-Landmark ·Rolf Marschalek	4
6	Validation of an ICH Q2 Compliant Flow Cytometry-Based Assay for the Assessment of the Inhibitory Potential of Mesenchymal Stromal Cells on T Cell Proliferation 2023 ·Cells ·(unknown), Melanie Bremm, (unknown), (unknown), (unknown), Halvard Bönig, (unknown), (unknown), Kathrin Vogelsang, (unknown), Rolf Marschalek, (unknown), Peter Bader, Zyrafete Kuçi, Selim Kuçi, Sabine Huenecke	4
7	HIV-1 Infection of Long-Lived Hematopoietic Precursors In Vitro and In Vivo 2022 ·Cells ·(unknown), (unknown), Hanna‐Mari Baldauf, Stefan Stein, Gerrit Kann, Markus Bickel, (unknown), Halvard Bönig, Rolf Marschalek, Michael A. Rieger, Ursula Dietrich, Ralf Duerr	11
8	The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemia 2022 ·Blood Advances ·Rahul Kumar, Raquel Pereira, (unknown), (unknown), (unknown), (unknown), (unknown), Valentina R. Minciacchi, Eric Kowarz, Melanie Meister, Parimala Sonika Godavarthy, Véronique Maguer‐Satta, Sylvain Lefort, Eliza Wiercinska, Halvard Bönig, Rolf Marschalek, Daniela S. Krause	11
9	Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab 2021 ·Pediatric Blood & Cancer ·Rosemary Sutton, Luciano Dalla Pozza, Seong Lin Khaw, Chris Fraser, Tom Révész, (unknown), Richard Mitchell, Toby N. Trahair, Caroline M. Bateman, Nicola C. Venn, Tamara Law, (unknown), Susan L. Heatley, Barbara J. McClure, Claus Meyer, Rolf Marschalek, Michelle J. Henderson, (unknown), Deborah L. White, Rishi S. Kotecha	17
10	Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosis 2021 ·Cancer Genetics ·(unknown), Bruno A. Lopes, (unknown), (unknown), Teresa de Souza Fernandez, Patrizia Larghero, (unknown), Gisele Loth, Lisandro Ribeiro, Carmen Bonfim, (unknown), Rolf Marschalek, Claus Meyer, Maria S. Pombo‐de‐Oliveira	2
11	Targeted Next-Generation Sequencing for Detecting MLL Gene Fusions in Leukemia 2017 ·Molecular Cancer Research ·Sadia Afrin, Christine Zhang, Claus Meyer, (unknown), Thy Pham, Timothy J. C. Bruxner, Nicola C. Venn, Toby N. Trahair, Rosemary Sutton, Rolf Marschalek, J. Lynn Fink, Andrew S. Moore	29
12	Hypoxia Causes Downregulation of Dicer in Hepatocellular Carcinoma, Which Is Required for Upregulation of Hypoxia-Inducible Factor 1α and Epithelial–Mesenchymal Transition 2017 ·Clinical Cancer Research ·Ahmed Atef Ibrahim, Christian Schmithals, (unknown), Verena Köberle, (unknown), Thomas Pleli, Otto Kollmar, (unknown), Oliver Waidmann, Fabian Finkelmeier, Stefan Zeuzem, Horst‐Werner Korf, Tobias Schmid, Andreas Weigert, Bernd Kronenberger, Rolf Marschalek, Albrecht Piiper	31
13	Relation between Genomic DNA Breakpoints in MLL Gene and Treatment Outcome in Infants with Acute Leukemia 2016 ·Clinical oncohematology ·(unknown), Claus Meyer, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rolf Marschalek, (unknown)	1
14	Revisiting the biology of infant t(4;11)/MLL-AF4+ B-cell acute lymphoblastic leukemia 2015 ·Blood ·Alejandra Sanjuán-Pla, Clara Bueno, Cristina Prieto, Pamela Acha, Ronald W. Stam, Rolf Marschalek, Pablo Menéndez	73
15	Effective Targeting of the P53–MDM2 Axis in Preclinical Models of Infant MLL -Rearranged Acute Lymphoblastic Leukemia 2015 ·Clinical Cancer Research ·Jennifer Richmond, Hernán Carol, Kathryn Evans, (unknown), (unknown), Alissa K. Robbins, Claus Meyer, Nicola C. Venn, Rolf Marschalek, Michelle J. Henderson, Rosemary Sutton, Raushan T. Kurmasheva, Ursula R. Kees, Peter J. Houghton, Malcolm A. Smith, Richard B. Lock	41
16	Genetic and clinical characterization of 45 acute leukemia patients with MLL gene rearrangements from a single institution 2012 ·Molecular Oncology ·Nuno Cerveira, Susana Lisboa, Cecília Correia, Susana Bizarro, Joana Santos, Lurdes Torres, Joana Vieira, João D. Barros‐Silva, (unknown), Cláudia Moreira, Claus Meyer, (unknown), (unknown), (unknown), Luísa Viterbo, (unknown), Rolf Marschalek, (unknown), José Mariz, Manuel R. Teixeira	13
17	NQO1 C609T polymorphism in distinct entities of pediatric hematologic neoplasms. 2004 ·PubMed ·(unknown), Martin Schrappe, Sabine Strehl, Alfred Reiter, Holger-Andreas Elsner, Jan Trka, Gunnar Cario, Susanne Viehmann, Jochen Harbott, Arndt Borkhardt, Markus Metzler, Thorsten Langer, Reinald Repp, Rolf Marschalek, Karl Welte, Oskar A. Haas, Martin Stanulla	29
18	The Structure of the Human ALL-1/MLL/HRX Gene 1997 ·Leukemia & lymphoma ·Rolf Marschalek, (unknown), (unknown), (unknown), Gabriele Margareta Siegler, Johann Greil, J. Beck, (unknown)	26
19	Structure of DRE, a Retrotransposable Element Which Integrates with Position Specificity Upstream of Dictyostelium discoideum tRNA Genes 1992 ·Molecular and Cellular Biology ·Rolf Marschalek, Jörg Hofmann, Gerald G. Schumann, (unknown), Theo Dingermann	36
20	tRNA ^Glu (GAA) Genes from the Cellular Slime Mold Dictyostelium discoideum 1989 ·DNA ·Theo Dingermann, (unknown), Rolf Marschalek, (unknown), Dennis L. Welker	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact